These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 38363244)

  • 21. Meningococcal serogroup B vaccination series initiation in the United States: A real-world claims data analysis.
    Packnett ER; Zimmerman NM; Novy P; Morgan LC; Chime N; Ghaswalla P
    Hum Vaccin Immunother; 2023 Dec; 19(1):2165382. PubMed ID: 36715008
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Updated Recommendations for Use of MenB-FHbp Serogroup B Meningococcal Vaccine - Advisory Committee on Immunization Practices, 2016.
    Patton ME; Stephens D; Moore K; MacNeil JR
    MMWR Morb Mortal Wkly Rep; 2017 May; 66(19):509-513. PubMed ID: 28520709
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Cohn AC; MacNeil JR; Clark TA; Ortega-Sanchez IR; Briere EZ; Meissner HC; Baker CJ; Messonnier NE;
    MMWR Recomm Rep; 2013 Mar; 62(RR-2):1-28. PubMed ID: 23515099
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Perceptions and Knowledge About the MenB Vaccine Among Parents of High School Students.
    Richardson E; Ryan KA; Lawrence RM; Harle CA; Young A; Livingston MD; Rawal A; Staras SAS
    J Community Health; 2021 Aug; 46(4):808-816. PubMed ID: 33389475
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcomes from the Use of Targeted Interventions to Increase Meningococcal Vaccination Rates in a Pediatric Clinic.
    Podraza L; Vasudevan J; Hudson C; Jayan A; Varman M
    J Community Health; 2022 Feb; 47(1):87-93. PubMed ID: 34389892
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of Serogroup B Meningococcal Vaccines in Adolescents and Young Adults: Recommendations of the Advisory Committee on Immunization Practices, 2015.
    MacNeil JR; Rubin L; Folaranmi T; Ortega-Sanchez IR; Patel M; Martin SW
    MMWR Morb Mortal Wkly Rep; 2015 Oct; 64(41):1171-6. PubMed ID: 26492381
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety and immunogenicity of a booster dose of meningococcal (groups A, C, W, and Y) polysaccharide diphtheria toxoid conjugate vaccine.
    Robertson CA; Greenberg DP; Hedrick J; Pichichero M; Decker MD; Saunders M
    Vaccine; 2016 Oct; 34(44):5273-5278. PubMed ID: 27642132
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A physician's guide to the 2-dose schedule of MenB-FHbp vaccine.
    McDaniel A; Dempsey A; Srivastava A
    Hum Vaccin Immunother; 2019; 15(11):2729-2737. PubMed ID: 30932730
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of Serogroup B Meningococcal Vaccines in Persons Aged ≥10 Years at Increased Risk for Serogroup B Meningococcal Disease: Recommendations of the Advisory Committee on Immunization Practices, 2015.
    Folaranmi T; Rubin L; Martin SW; Patel M; MacNeil JR;
    MMWR Morb Mortal Wkly Rep; 2015 Jun; 64(22):608-12. PubMed ID: 26068564
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Meningococcal vaccination in patients with newly diagnosed asplenia in the United States.
    Ghaswalla PK; Bengtson LGS; Marshall GS; Buikema AR; Bancroft T; Schladweiler KM; Koep E; Novy P; Hogea CS
    Vaccine; 2021 Jan; 39(2):272-281. PubMed ID: 33309081
    [TBL] [Abstract][Full Text] [Related]  

  • 31. National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2019.
    Elam-Evans LD; Yankey D; Singleton JA; Sterrett N; Markowitz LE; Williams CL; Fredua B; McNamara L; Stokley S
    MMWR Morb Mortal Wkly Rep; 2020 Aug; 69(33):1109-1116. PubMed ID: 32817598
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence of Meningococcal Disease Before and After Implementation of Quadrivalent Meningococcal Conjugate Vaccine in the United States.
    Mbaeyi S; Pondo T; Blain A; Yankey D; Potts C; Cohn A; Hariri S; Shang N; MacNeil JR
    JAMA Pediatr; 2020 Sep; 174(9):843-851. PubMed ID: 32687590
    [TBL] [Abstract][Full Text] [Related]  

  • 33. National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2020.
    Pingali C; Yankey D; Elam-Evans LD; Markowitz LE; Williams CL; Fredua B; McNamara LA; Stokley S; Singleton JA
    MMWR Morb Mortal Wkly Rep; 2021 Sep; 70(35):1183-1190. PubMed ID: 34473682
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Knowledge and Attitudes Regarding Category B ACIP Recommendations Among Primary Care Providers for Children.
    Kempe A; Allison MA; MacNeil JR; O'Leary ST; Crane LA; Beaty BL; Hurley LP; Brtnikova M; Lindley MC; Liang JL; Albert AP; Smith JC
    Acad Pediatr; 2018; 18(7):763-768. PubMed ID: 29678594
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Meningococcal B vaccination coverage among older adolescents in the United States.
    La EM; Garbinsky D; Hunter S; Poston S; Novy P; Ghaswalla P
    Vaccine; 2021 May; 39(19):2660-2667. PubMed ID: 33849722
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Survey of pediatricians in Germany reveals important challenges for possible implementation of meningococcal B vaccination.
    Takla A; Wichmann O; Koch J; Terhardt M; Hellenbrand W
    Vaccine; 2014 Nov; 32(48):6349-55. PubMed ID: 25280437
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Young Adult and Parent Willingness to Pay for Meningococcal Serogroup B Vaccination.
    Huang L; Srivastava A; Fairchild A; Whittington D; Johnson R
    MDM Policy Pract; 2024; 9(2):23814683241264280. PubMed ID: 39139368
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Understanding Factors Affecting University A Students' Decision to Receive an Unlicensed Serogroup B Meningococcal Vaccine.
    Breakwell L; Vogt TM; Fleming D; Ferris M; Briere E; Cohn A; Liang JL
    J Adolesc Health; 2016 Oct; 59(4):457-64. PubMed ID: 27523976
    [TBL] [Abstract][Full Text] [Related]  

  • 39. National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2017.
    Walker TY; Elam-Evans LD; Yankey D; Markowitz LE; Williams CL; Mbaeyi SA; Fredua B; Stokley S
    MMWR Morb Mortal Wkly Rep; 2018 Aug; 67(33):909-917. PubMed ID: 30138305
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factors Associated With Receipt of Meningococcal B Vaccine Among United States Adolescents, National Immunization Survey-Teen, 2017-2018.
    Hansen CE; Niccolai LM
    J Adolesc Health; 2021 Nov; 69(5):769-773. PubMed ID: 34148798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.